Overview

To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effect of food on the pharmacokinetics of AZD0328 in healthy male volunteers. AZD0328 will be administered as a single oral dose (capsule) during two treatment periods, after food intake or during fasting condition.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca